Brenda L. Banwell MDProfessor of Neurology and Pediatrics, Chief of Neurology, Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Dr. Banwell currently serves as the Chief of Child Neurology and Director of the Neuroscience Center, Professor of Neurology and Pediatrics, and the Grace Loeb Chair in Neuroscience, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Dr. Banwell's clinical and research focus is in the area of pediatric multiple sclerosis and she has led a large North American prospective study of clinical outcomes, genetics, immunology and neuroimaging features of MS in children. Dr. Banwell has over 300 published manuscripts and 30 book chapters.
Dr. Banwell serves as the Chair of the International Pediatric Multiple Sclerosis Study Group as well as Chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation. Dr. Banwell is a Director of the American Academy of Neurology.
Dr. Banwell studied medicine at the University of Western Ontario, followed by residencies in Pediatrics at the University of Western Ontario and Child Neurology at the University of Toronto. She then pursued a Neuromuscular Fellowship at the Mayo Clinic, Rochester, Minnesota. Dr. Banwell was appointed as an Assistant Professor of Pediatrics and Neurology at The Hospital for Sick Children, University of Toronto in 1999, and rose to the rank of Full Professor at the University of Toronto prior to relocating to The Children's Hospital of Philadelphia in 2012. Dr. Banwell is an Adjunct Senior Scientist in the Research Institute at The Hospital for Sick Children and an Adjunct Professor at McGill University.
Dr. Banwell serves as a consultant to Novartis, Roche, UCB, Sanofi-Genzyme, and UTSW in the capacity as an advisor, safety monitor, or as a central MRI reviewer for clinical trials.